...
首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study
【24h】

PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study

机译:PLGA纳米粒用于眼部递送洛替泼诺依他宝酯的眼角膜渗透研究

获取原文

摘要

Abstract The purpose of the present study was to develop loteprednol etabonate (LE) loaded poly( d , l -lactide co-glycolide) (PLGA) nanoparticles (NPs) and study their penetration profile into the excised goat cornea. In the present study, LE loaded PLGA NPs were prepared by solvent evaporation with high speed homogenization method and the penetration profile was studied using confocal laser scanning microscopy (CLSM). Rhodamine (Rd) was used as a fluorescent marker to prepare Rd-LE–PLGA-NPs. The NPs were characterized for particle size, X-ray diffraction (XRD), differential scanning calorimetry (DSC), transmission electron microscopy (TEM), drug entrapment, and permeation profile. Intense fluorescence observed across the depths of goat corneal tissue suggested an improved penetration profile of NPs. The entrapment efficiency and mean diameter of the optimized formulation (F5) were found to be 96.31?±?1.68% and 167.6?±?0.37?nm, respectively. These findings indicate that LE loaded PLGA NPs may serve as a potential drug carrier for ocular administration in eye disease.
机译:摘要本研究的目的是开发载有氯替泼诺乙炔酸酯(LE)的聚(d,l-丙交酯乙交酯)(PLGA)纳米颗粒(NPs),并研究其在切下的山羊角膜中的渗透特性。在本研究中,通过溶剂均化和高速均质化方法制备了LE负载的PLGA NP,并使用共聚焦激光扫描显微镜(CLSM)研究了其穿透特性。罗丹明(Rd)被用作荧光标记来制备Rd-LE-PLGA-NP。 NP的特征在于粒径,X射线衍射(XRD),差示扫描量热法(DSC),透射电子显微镜(TEM),药物截留和渗透曲线。在山羊角膜组织的深处观察到强烈的荧光提示NPs的渗透性改善。优化配方(F5)的包封率和平均直径分别为96.31±1.68%和167.6±0.37nm。这些发现表明,载有LE的PLGA NP可以作为眼部疾病眼部给药的潜在药物载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号